MBBS (Hon-1), FRCR (UK), MMed (Diag Radiol), MCI (S’pore)
Specialty: Oncologic Imaging
Sub-specialties: Breast ＆ Body Imaging (Colorectal, Gynae-Oncology, Hepato-Pancreato-Biliary, Uro-Oncology)
Conditions Treated by this Doctor:
Breast Cancer , Colorectal Cancer, Gynaecology, Hepato-Pancreato-Biliary Cancers, Ovarian Cancer, Prostate Cancer, Treatment for Prostate Cancer, Uro-Oncology, Uterine Cancer.
Dr Hennedige graduated from Monash University in Australia with first class honours in 2005 and received her post-graduate FRCR and MMed degrees in Diagnostic Radiology in 2011. She did basic and advanced training in Diagnostic Radiology in Singapore then joined the National Cancer Centre in 2014 as an Associate Consultant. She has a strong research record which lies primarily in the realm of body oncology imaging with nearly 30 peer-reviewed publications and has presented papers and posters both locally and internationally including Asian Oceanian Congress of Radiology, Scientific Assembly and Annual Meeting of the Radiological Society of North America, International Cancer Imaging So-ciety Meeting, CRI-CIMT-EATI-AACR International Cancer Immunotherapy Conference and An-nual Scientific Meeting of the Singapore Radiological Society and College of Radiologists. She also attained the Masters of Clinical Investigation from NUS, Singapore in 2017 and has gar-nered research grants amounting to over S$200,000.
Dr Hennedige is a Fellow of the Royal College of Radiologists and Member of the International Cancer Imaging Society, Golden Key International Honour Society, Singapore Radiological So-ciety, Singapore Medical Association and Radiological Society of North America.
1. Tai D, Loke K, Gogna A, Kaya NA, Tan SH, Hennedige T, Ng D, Irani F, Lee J, Lim JQ, Too CW, Ng MCH, Tham CK, Lam J, Koo SL, Chong HS, Goh GB, Huang HL, Venkatanarasimha N, Lo R, Chow PKH, Goh BKP, Chung A, Toh HC, Thng CH, Lim TKH, Yeong J, Zhai W, Chan CY, Choo SP. Radioembolisation with Y90-resin microspheres followed by nivolumab for advanced hepatocellular carcinoma (CA 209-678): a single arm, single centre, phase 2 trial. Lancet Gastroenterol Hepatol. 2021 Dec;6(12):1025-1035. 2. Sommat K, Lin JYX, Chew MML, Loh CS, Liew JSK, Foo YW, Kwek JW, Hennedige T, Goh JPS, Tan TK. Non-anesthetist-administered moderate sedation with midazolam and fentanyl for outpatient MRI-aided hybrid intracavitary and interstitial brachytherapy in cervix cancer: a single-institution experience. J Contemp Brachytherapy. 2021 Jun;13(3):286-293. 3. Akram F, Koh PE, Wang F, Zhou S, Tan SH, Paknezhad M, Park S, Hennedige T, Thng CH, Lee HK, Sommat K. Exploring MRI based radiomics analysis of intratumoral spatial heterogeneity in locally advanced nasopharyngeal carcinoma treated with intensity modulated radiotherapy. PLoS One. 2020 Oct 5;15(10):e0240043. 4. Wong DJ, Lee J, Choo SP, Thng CH, Hennedige T. Hyperprogressive disease in hepatocellular carcinoma with immune checkpoint inhibitor use: a case series. Immunotherapy. 2019 Feb;11(3):167-175. 5. Srinivasan N, Teo JY, Chin YK, Hennedige T, Tan DM, Low AS, Thng CH, Goh BKP. Systematic review of the clinical utility and validity of the Sendai and Fukuoka Consensus Guidelines for the management of intraductal papillary mucinous neoplasms of the Pancreas. HPB (Oxford). 2018 Feb 24. 6. Chew MH, Yeh YT, Toh EL, Sumarli SA, Chew GK, Lee LS, Tan MH, Hennedige TP, Ng SY, Lee SK, Chong TT, Abdullah HR, Goh TLH, Rasheed MZ, Tan KC, Tang CL. Critical evaluation of contemporary management in a new Pelvic Exenteration Unit: The first 25 consecutive cases. World J Gastrointest Oncol. 2017 May 15; 9(5): 218-27. 7. Hennedige T, Ng DCE, Tao M, Quek RHH, Lim ST, Kwek JW. Evaluation of whole body diffusion-weighted imaging in the staging and treatment response of lymphoma compared with FDG PET/CT as a reference standard. Radiol Open J. 2017; 2(1):17-25. 8. Hennedige TP, Wang G, Leung FP, Alsaif HS, Teo LL, Lim SG, Wee A, Venkatesh SK. Magnetic Resonance Elastography and Diffusion Weighted Imaging in the Evaluation of Hepatic Fibrosis in Chronic Hepatitis B. Gut Liver. 2016 Dec 16. 9. Hennedige TP, Hallinan JT, Leung FP, Teo LL, Iyer S, Wang G, Chang S, Madhavan KK, Wee A, Venkatesh SK. Comparison of magnetic resonance elastography and diffusion-weighted imaging for differentiating benign and malignant liver lesions. Eur Radiol. 2016 Feb;26(2):398-406. 10. Hennedige T, Venkatesh SK. Advances in computed tomography and magnetic resonance imaging of hepatocellular carcinoma. World J Gastroenterol. 2016 Jan 7;22(1):205-20.11. Hennedige T, Yang ZJ, Ong CK, Venkatesh SK. Utility of non-contrast-enhanced CT for improved detection of arterial phase hyperenhancement in hepatocellular carcinoma. Abdom Imaging. 2014 Dec;39(6): 1247-54. 12. Hennedige T, Neo WT, Venkatesh SK. Imaging of malignancies of the biliary tree- An update. Cancer Imaging 2014; 14:14.13. Hennedige TP, Venkatesh SK. Imaging of Hepatocellular carcinoma: diagnosis, staging and treatment monitoring. Cancer Imaging 2013 Feb:12(3):530-547.14. Huellner MW, Hennedige TP, Winterhalder R, Zander T, Venkatesh SK, Yong WP, Soo RA, Seifert B, Treumann TC, Strobel K, Veit-Haibach P. Prognostic value of different CT measurements in early therapy response evaluation in patients with metastatic colorectal cancer. Cancer Imaging. 2012 May 21;12:212-24. 15. Hennedige T, Teo L, Ang B, Cheong WK, Venkatesh SK. Accuracy of preoperative CT for local staging in colorectal carcinomas. Singapore Med J. 2010 Jun;51(6):475-80.
Subscribe to our mailing list to get the updates to your email inbox...
11 Hospital Crescent, Singapore 169610 +65 6436 8000